UAE: Julphar Pharma in crisis


Issue 1079 - 26 Apr 2019 | 2 minute read

Shares in Julphar Pharmaceuticals have been suspended on the Abu Dhabi Securities Exchange (ADX), following a saga in which the disastrous handling of product suspensions in Saudi Arabia last year jeopardised the company’s wider marketing and operations. Although publicly quoted, members of Ras Al-Khaimah’s royal family have retained a large stake in the company, which was founded in 1980 by RAK’s late ruler Sheikh Saqr Bin Mohammed Al-Qasimi. The share suspension led to the resignation on 17 April of company chairman Sheikh Faisal Bin Saqr Bin Mohammed Al-Qasimi and his son, Julphar vice chairman Sheikh Abdullah Bin Faisal Al-Qasimi.

Want to read more?

Subscribe to Gulf States Newsletter

View subscription options

Join our community

Sign up for an account to gain:

  • Set up news alerts on the countries and sectors that matter to you.
  • Free access to newsletter articles under 100 words.
  • Free access to GSN View articles articles.


View a selection of Free articles

Explore subscription options

Follow us on Google News